Skip to main content
. 2021 Mar 19;45(5):68. doi: 10.3892/or.2021.8019

Figure 4.

Figure 4.

Pharmacological inhibitors of CBS and CSE with anticancer activity in other tumors, but no reports yet in breast cancer. These inhibitors of CBS or CSE possess anticancer activities in gastric, liver and colon cancer as well as other cancer tissues, but their roles in breast cancer have yet to be reported. CBS, cystathionine β-synthase; CSE, cystathionine γ-lyase; PAG, propargylglycine.